Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pneumococcal histidine triad (Pht) proteins are a family of four surface-exposed proteins (PhtA, PhtB, PhtD, and PhtE) found in Streptococcus pneumoniae (UniProt, 2024). These proteins are characterized by the presence of several histidine triad (HxxHxH) motifs, which are essential for binding and acquiring zinc from the host environment, a process critical for bacterial growth and survival (Rioux et al., 2011). Beyond metal homeostasis, Pht proteins contribute to virulence by inhibiting the deposition of complement component C3b on the bacterial surface, thereby allowing the pathogen to evade opsonophagocytosis by host immune cells (Ogunniyi et al., 2009). Because they are highly conserved across nearly all pneumococcal serotypes, Pht proteins—particularly PhtD—have been extensively developed as antigens for next-generation, serotype-independent vaccines (Plumptre et al., 2013). Clinical trials have demonstrated that vaccines containing PhtD can induce robust antibody responses and provide protection against invasive pneumococcal disease and pneumonia in animal models and human subjects (Godfroid et al., 2011). These proteins represent a significant shift in vaccine strategy from targeting serotype-specific polysaccharides to targeting conserved protein antigens. The interaction between Pht proteins and the host immune system is the primary focus of their therapeutic application. Research continues to evaluate their efficacy in combination with other pneumococcal proteins to ensure broad-spectrum immunity (Pichichero, 2017).
Induction of antigen-specific antibodies that facilitate opsonophagocytosis and neutralize the protein's role in immune evasion and metal acquisition (Plumptre et al., 2013; Godfroid et al., 2011).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pneumococcal histidine triad protein (Pht) (Pht).